Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling
- PMID: 20554423
- PMCID: PMC2970646
- DOI: 10.1016/j.pec.2010.05.011
Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling
Abstract
Objective: Evaluate a computer-assisted telephone counseling (CATC) decision aid for men considering a prostate specific antigen (PSA) test.
Methods: Eligible men were invited by their primary care providers (PCPs) to participate. Those consenting received an educational booklet followed by CATC. The counselor assessed stage of readiness, reviewed booklet information, corrected knowledge deficits and helped with a values clarification exercise. The materials presented advantages and disadvantages of being screened and did not advocate for testing or for not testing. Outcome measures included changes in stage, decisional conflict, decisional satisfaction, perceived vulnerability and congruence of a PSA testing decision with a pros/cons score. Baseline and final surveys were administered by telephone.
Results: There was an increase in PSA knowledge (p<0.001), and in decisional satisfaction (p<0.001), a decrease in decisional conflict (p<0.001), and a general consistency of those decisions with the man's values. Among those initially who had not made a decision, 83.1% made a decision by final survey with decisions equally for or against screening.
Conclusions: The intervention provides realistic, unbiased and effective decision support for men facing a difficult and confusing decision.
Practice implications: Our intervention could potentially replace a discussion of PSA testing with the PCP for most men.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Figures

References
-
- US Preventive Services Task Force. Prostate Cancer Screening Recommendations. [3/4/2009]. http://www.ahrq.gov/clinic/uspstf/uspsprca.htm.
-
- Woolf SH, Krist AH. Shared decision making for prostate cancer screening: Do patients or clinicians have a choice? Archives of Internal Medicine. 2009;169:1557–1559. - PubMed
-
- Andriole GL, Grubb RL, 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, Crawford ED, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team Mortality results from a randomized prostate cancer screening trial. New England Journal of Medicine. 2009;360(13):1310–1319. - PMC - PubMed
-
- Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine. 2009;360(13):1320–1328. - PubMed
-
- Sheridan SL, Harris RP, Woolf SH, Shared Decisionmaking Workgroup of the United States Preventive Services Task Force Shared Decisionmaking About Screening and Chemoprevention: A Suggested Approach from the U.S. Preventive Services Task Force. (Background Article) [01/16/2009]. http://www.ahrq.gov/clinic/3rduspstf/shared/sharedba2.htm. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous